Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
After finishing at $1.32 in the prior trading day, Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) closed at $1.34, up 1.52%. In other words, the price has increased by $1.52 from its previous closing price. On the day, 1.86 million shares were traded. LXRX stock price reached its highest trading level at $1.35 during the session, while it also had its lowest trading level at $1.28.
Ratios:
Our goal is to gain a better understanding of LXRX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.63 and its Current Ratio is at 5.64. In the meantime, Its Debt-to-Equity ratio is 0.54 whereas as Long-Term Debt/Eq ratio is at 0.53.
Upgrades & Downgrades
In the most recent recommendation for the company, Leerink Partners on March 05, 2025, Downgraded its rating to Market Perform and sets its target price to $1 from $2 previously.
On June 17, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.
On April 30, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $5.Leerink Partners initiated its Outperform rating on April 30, 2024, with a $5 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LXRX now has a Market Capitalization of 486954464 and an Enterprise Value of 435954240. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.87 while its Price-to-Book (P/B) ratio in mrq is 4.05. Its current Enterprise Value per Revenue stands at 6.152 whereas that against EBITDA is -8.082.
Stock Price History:
The Beta on a monthly basis for LXRX is 0.98, which has changed by 0.65432096 over the last 52 weeks, in comparison to a change of 0.1028198 over the same period for the S&P500. Over the past 52 weeks, LXRX has reached a high of $1.66, while it has fallen to a 52-week low of $0.28. The 50-Day Moving Average of the stock is -3.28%, while the 200-Day Moving Average is calculated to be 44.32%.
Shares Statistics:
The stock has traded on average 2.34M shares per day over the past 3-months and 2490890 shares per day over the last 10 days, according to various share statistics. A total of 363.40M shares are outstanding, with a floating share count of 184.00M. Insiders hold about 49.37% of the company’s shares, while institutions hold 23.63% stake in the company. Shares short for LXRX as of 1761868800 were 27704594 with a Short Ratio of 11.84, compared to 1759190400 on 27299898. Therefore, it implies a Short% of Shares Outstanding of 27704594 and a Short% of Float of 21.290001.
Earnings Estimates
The dynamic stock of Lexicon Pharmaceuticals Inc (LXRX) is currently being evaluated by a team of 5.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.05 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.16 and -$0.18 for the fiscal current year, implying an average EPS of -$0.17. EPS for the following year is -$0.26, with 5.0 analysts recommending between -$0.19 and -$0.32.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for LXRX’s current fiscal year. The highest revenue estimate was $51.1M, while the lowest revenue estimate was $44.31M, resulting in an average revenue estimate of $47.46M. In the same quarter a year ago, actual revenue was $31.08M
